Your browser doesn't support javascript.
loading
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
Harthaller, Teresa; Falkensammer, Barbara; Bante, David; Huber, Maria; Schmitt, Melanie; Benainouna, Habib; Rössler, Annika; Fleischer, Verena; von Laer, Dorothee; Kimpel, Janine; Würzner, Reinhard; Borena, Wegene.
Affiliation
  • Harthaller T; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Falkensammer B; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Bante D; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Huber M; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Schmitt M; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Benainouna H; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Rössler A; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Fleischer V; Department of Hygiene, Microbiology and Public Health, Institute of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
  • von Laer D; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Kimpel J; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
  • Würzner R; Department of Hygiene, Microbiology and Public Health, Institute of Hygiene and Medical Microbiology, Innsbruck Medical University, Innsbruck, Austria.
  • Borena W; Department of Hygiene, Microbiology and Public Health, Institute of Virology, Innsbruck Medical University, Innsbruck, Austria.
Front Immunol ; 14: 1196988, 2023.
Article in En | MEDLINE | ID: mdl-37545492
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article